Promised Products

- the broadest spectrum beta-lactam antibiotic   - act bactericidally against virtually all clinically significant pathogens   - highly resistant to degradation by bacterial beta-lactamases   - effective therapy of severe and live-threatening polymicrobic and mixed aerobic/anaerobic infections


Most effective antibiotic for de-escalation therapy of severe and life-threatening infection caused by poly-resistant bacteria in any localization


- broad-spectrum tetracycline antibiotic  - high activity against atypical pathogens and intracellular parasites  - drug of choice for the treatment of infection caused by Mycoplasma, Chlamydia, Chlamydophila, Ureaplasma (incl. PID and respiratory tract infections)  - use for the treatment of plague, tularemia, brucellosis, Lime disease, infections caused by Rickettsiae, etc


- excellent selective activity against Gram-negative aerobic bacteria   - effective therapy of infection caused by polyresistant pathogens   - minimum adverse reactions   - can be used in patient with allergy to penicillines and cephalosporines


GMP

GMP – key principals
 
GMP refers to the Good Manufacturing Practice Regulations promulgated by the US Food and Drug Administration under the authority of the Federal Food, Drug, and Cosmetic Act. These regulations, which have the force of law, require that manufacturers, processors, and packagers of drugs, medical devices, some food, and blood take proactive steps to ensure that their products are safe, pure, and effective. GMP regulations require a quality approach to manufacturing, enabling companies to minimize or eliminate instances of contamination, mixups, and errors. This in turn, protects the consumer from purchasing a product which is not effective or even dangerous. Failure of firms to comply with GMP regulations can result in very serious consequences including recall, seizure, fines, and jail time.
GMP regulations address issues including recordkeeping, personnel qualifications, sanitation, cleanliness, equipment verification, process validation, and complaint handling. Most GMP requirements are very general and open-ended, allowing each manufacturer to decide individually how to best implement the necessary controls. This provides much flexibility, but also requires that the manufacturer interpret the requirements in a manner which makes sense for each individual business.
GMP is also sometimes referred to as "cGMP". The "c" stands for "current," reminding manufacturers that they must employ technologies and systems which are up-to-date in order to comply with the regulation. Systems and equipment used to prevent contamination, mixups, and errors, which may have been "top-of-the-line" 20 years ago, may be less than adequate by today's standards.
 
ABOLmed LLC is operating according to Russian and EU GMP standards. Now and in future ABOLmed LLC continues auditing program to verifies adherence to GMP, appropriate training of employees and that resources are being utilized as efficiently as possible.
 
WHO’s view on norms and standards of quality, safety and efficacy of medicines
 
Why is GMP important?
Poor quality medicines are not only a health hazard, but a waste of money for both governments and individual consumers.
 
Poor quality medicines can damage health
A poor quality medicine may contain toxic substances that have been unintentionally added.
A medicine that contains little or none of the claimed ingredient will not have the intended therapeutic effect.
 
GMP helps boost pharmaceutical export opportunities
Most countries will only accept import and sale of medicines that have been manufactured to internationally recognized GMP. Governments seeking to promote their countries' export of pharmaceuticals can do so by making GMP mandatory for all pharmaceutical production and by training their inspectors in GMP requirements.
 
What is GMP?
Good manufacturing practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product. The main risks are: unexpected contamination of products, causing damage to health or even death; incorrect labels on containers, which could mean that patients receive the wrong medicine; insufficient or too much active ingredient, resulting in ineffective treatment or adverse effects. GMP covers all aspects of production; from the starting materials, premises and equipment to the training and personal hygiene of staff. Detailed, written procedures are essential for each process that could affect the quality of the finished product. There must be systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process - every time a product is made. WHO has established detailed guidelines for good manufacturing practice. Many countries have formulated their own requirements for GMP based on WHO GMP. Others have harmonized their requirements, for example in the Association of South-East Asian Nations (ASEAN), in the European Union and through the Pharmaceutical Inspection Convention.
 
Is GMP necessary if there is a quality control laboratory?
Yes. Good quality must be built in during the manufacturing process; it cannot be tested into the product afterwards. GMP prevents errors that cannot be eliminated through quality control of the finished product. Without GMP it is impossible to be sure that every unit of a medicine is of the same quality as the units of medicine tested in the laboratory.
 
Can manufacturers afford to implement GMP?
Yes. Making poor quality products does not save money. In the long run, it is more expensive finding mistakes after they have been made than preventing them in the first place. GMP is designed to ensure that mistakes do not occur. Implementation of GMP is an investment in good quality medicines. This will improve the health of the individual patient and the community, as well as benefiting the pharmaceutical industry and health professionals. Making and distributing poor quality medicines leads to loss of credibility for everyone: both public and private health care and the manufacturer.

 
Contacts:
Lesnaya str., 59/3, Moscow, Russia, 127005
Tel: +7 495 660-91-10,
Fax +7 495 660-91-06
1998-2009 ABOLmed LLC. © All right reserved
Яндекс цитирования Rambler's Top100